Search

Search Constraints

You searched for: Author/Creator Andreoni, M.

Search Results

11. Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries. (3rd September 2019)

12. HBsAg mutations correlated with HCC in vivo affect HBsAg release and favor cell proliferation in vitro. (10th February 2016)

13. HBV-HDV co-infection constrains HBV genetic evolution in HBsAg. (10th February 2016)

14. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

15. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017)

16. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study. (10th February 2016)

17. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia. (23rd February 2015)

18. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016)

19. In HBeAg-negative chronic HBV infection, HBsAg levels profoundly differ among HBV-genotypes and can be affected by the extent of HBsAg variability: Can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?. Issue 1 (16th February 2017)

20. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. (April 2017)